Persistent URL of this record https://hdl.handle.net/1887/101180
In Collections
This item can be found in the following collections:
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- All authors
- Phillips, K.A.; Milne, R.L.; Rookus, M.A.; Daly, M.B.; Antoniou, A.C.; Peock, S.; Frost, D.; Easton, D.F.; Ellis, S.; Friedlander, M.L.; Buys, S.S.; Andrieu, N.; Nogues, C.; Stoppa-Lyonnet, D.; Bonadona, V.; Pujol, P.; McLachlan, S.A.; John, E.M.; Hooning, M.J.; Seynaeve, C.; Tollenaar, R.A.E.M.; Goldgar, D.E.; Terry, M.B.; Caldes, T.; Weideman, P.C.; Andrulis, I.L.; Singer, C.F.; Birch, K.; Simard, J.; Southey, M.C.; Olsson, H.L.; Jakubowska, A.; Olah, E.; Gerdes, A.M.; Foretova, L.; Hopper, J.L.
- Date
- 2013-09-01
- Journal
- Journal of Clinical Oncology
- Volume
- 31
- Issue
- 25
- Pages
- 3091 - +